Shandong Weigao repurchases shares, boosting treasury holdings

Shandong Weigao Group Medical Polymer Company Limited completed a share repurchase on September 18, 2025, acquiring 540,000 ordinary H shares. The shares were repurchased on the Exchange at prices ranging from HK$5.85 to HK$5.9, for an aggregate price paid of HK$3,168,200. These repurchased shares are now held as treasury shares.

Following this transaction, the company's issued shares (excluding treasury shares) decreased to 4,500,930,324 from an opening balance of 4,501,470,324. Concurrently, the number of treasury shares increased to 21,402,000, up from 20,862,000. The repurchase represents a 0.012% change relative to the existing number of issued shares before the event.

The repurchase was conducted under a mandate granted on May 27, 2025, which authorized the company to repurchase up to 451,560,392 shares. To date, 14,753,600 shares have been repurchased, representing 3.2672% of the issued shares at the mandate date. A moratorium period for new share issues or treasury share sales is in effect until October 18, 2025.